🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall study objectives are to determine whether carbidopa (Lodosyn®) ...
Status
Completed
Location
NYU Langone Medical Center, Dyautonomia Center, Suite 9Q
Start Date
2015-09
Trial ID
NCT02553265
Treatments Being Tested
This study will be an open-label, randomized, three-period cross-over pharm...
Status
Completed
Location
Site #001
Start Date
2016-06
Trial ID
NCT02812394
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness (how ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-26
Trial ID
NCT03235037
Treatments Being Tested
The purpose of this study is to study different kinds of dyskinesias in adv...
Status
Completed
Location
Uppsala University Hospital
Start Date
2008-02
Trial ID
NCT00888186
Treatments Being Tested
The purpose of this study is to evaluate treatments designed to improve coc...
Status
Completed
Location
Behavioral and Biomedical Sciences Building
Start Date
2011-06
Trial ID
NCT01393457
Treatments Being Tested
Hypothesis: We hypothesize that carbidopa in daily doses of 450mg will ente...
Status
Completed
Location
Oregon Health & Science University
Start Date
2009-03
Trial ID
NCT01399905
Treatments Being Tested
The purpose of this study is to evaluate the use of electroretinogram (ERG)...
Status
Completed
Location
Atlanta VA Medical Center
Start Date
2016-01
Trial ID
NCT02706977
This is a multicenter, randomized, double blind, placebo controlled paralle...
Status
Withdrawn
Location
Haddasah Ein Kerem Medical center
Start Date
2016-08
Trial ID
NCT02782481
the investigators hypothesise that 18F-FDOPA PET kinetic parameters are goo...
Status
Recruiting
Location
CHRU Nancy
Start Date
2023-06-13
Trial ID
NCT05512403
Treatments Being Tested
The purpose of this study was to assess the safety and tolerability of ABBV...
Status
Completed
Location
University of Alabama at Birmingham - Main /ID# 207996
Start Date
2019-04-29
Trial ID
NCT03781167
Treatments Being Tested